Home
Matthew T. Wiley, Chief Commercial Officer: Definium Therapeutics DFTX Sell · Filed 06/26
Trade details
- Type
- Insider sale
- Amount
- $129,101.01
- Shares · price
- 2,867 sh · $45.03 a share
- Held after
- 174,633 sh
- Trade date
- 26/06/25
- Filed
- 26/06/26
- Days to filing
- 1 days
Sold 1.6% of holdings
- Share of holding sold
- 1.6%
Definium Therapeutics trades, last 26 weeks
What else happened in Definium Therapeutics around then
Filed or reported within 30 days of the trade day · 05/26~07/25Matthew T. Wiley's recent trades
- Matthew T. Wiley
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 planDefinium Therapeutics
DFTX
$113.3K
3,097 sh
$113.3K
Filed 09/29
Traded 09/25
- Matthew T. Wiley
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$113.8K
3,097 sh
$113.8K
Filed 09/25
Traded 09/25
- Matthew T. Wiley
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$120.8K
2,867 sh
$120.8K
Filed 06/25
Traded 06/25
- Matthew T. Wiley
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$3,450
6,272 sh
$3,450
Filed 24/10/03
Traded 24/10/03
- Matthew T. Wiley
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$148
215 sh
$148
Filed 24/09/17
Traded 24/09/16
